James R. Empfield is EVP, Drug Discovery of Xenon Pharmaceuticals Inc.. Currently has a direct ownership of 10,000 shares of XENE, which is worth approximately $394,799. The most recent transaction as insider was on Aug 12, 2022, when has been sold 7,257 shares (Common Shares) at a price of $38.02 per share, resulting in proceeds of $275,911. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10K
0% 3M change
0% 12M change
Total Value Held $394,799

JAMES R. EMPFIELD Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 12 2022
SELL
Payment of exercise price or tax liability
$275,911 $38.02 p/Share
7,257 Reduced 9.68%
67,743 Common Shares
Aug 12 2022
SELL
Open market or private sale
$2,216,176 $38.38 p/Share
57,743 Reduced 85.24%
10,000 Common Shares
Aug 12 2022
BUY
Exercise of conversion of derivative security
$255,450 $3.93 p/Share
65,000 Added 46.43%
75,000 Common Shares
Mar 07 2022
SELL
Payment of exercise price or tax liability
$291,629 $30.23 p/Share
9,647 Reduced 18.38%
42,853 Common Shares
Mar 07 2022
SELL
Open market or private sale
$1,004,645 $30.58 p/Share
32,853 Reduced 76.66%
10,000 Common Shares
Mar 07 2022
BUY
Exercise of conversion of derivative security
$322,150 $7.58 p/Share
42,500 Added 45.07%
51,805 Common Shares
Mar 04 2022
SELL
Open market or private sale
$563,919 $30.79 p/Share
18,315 Reduced 64.68%
10,000 Common Shares
Mar 04 2022
SELL
Payment of exercise price or tax liability
$210,043 $31.42 p/Share
6,685 Reduced 19.1%
28,315 Common Shares
Mar 04 2022
BUY
Exercise of conversion of derivative security
$210,000 $8.4 p/Share
25,000 Added 41.67%
35,000 Common Shares
JRE

James R. Empfield

EVP, Drug Discovery
Burnaby, A1

Track Institutional and Insider Activities on XENE

Follow Xenon Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XENE shares.

Notify only if

Insider Trading

Get notified when an Xenon Pharmaceuticals Inc. insider buys or sells XENE shares.

Notify only if

News

Receive news related to Xenon Pharmaceuticals Inc.

Track Activities on XENE